@ShahidNShah
Study to Evaluate Efficacy of Telehealth Cognitive Behavioral Therapy for Migraine
Study will analyze whether cognitive behavioral therapy telehealth can lower headache days and disability as effectively as cognitive behavioral therapy plus a preventive medication for migraine. A new study will analyze the efficacy of cognitive behavioral therapy (CBT) delivered via telehealth in decreasing total headache days and disability from migraine vs CBT plus a preventive medication. The researchers, led by Scott Powers, PhD, Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, will analyze whether CBT telehealth can lower headache days and disability as effectively as CBT telehealth plus amitriptyline, a preventive medication for migraine.
Continue reading at pharmacytimes.com
Make faster decisions with community advice
- Advanced Wound Care Management Market: Rising Prevalence of Chronic Wounds to Drive the Market
- Digital health unicorn Truepill conducts third round of layoffs in 2022
- Evio & Aetion Partner to Deliver Real-World Evidence (RWE) Across the Pharmacy Value Chain
- ExtraHop Benchmarking Cyber Risk and Readiness Report Highlights Prevalence and Risks of Internet-Exposed Protocols on Organizations’ Networks
- Government Surveillance Report
Next Article
-
Wolters Kluwer Supports Second Mercy Ships Floating Hospital to Enhance use of Evidence-Based Medicine
The Global Mercy joins Africa Mercy with donation of three clinical decisions support tools to aid clinicians onboard ships in providing the best care anywhere around the world. Wolters Kluwer, Health …
Posted Aug 13, 2022 Hospital Evidence-Based Care